Autoimmune hepatitis

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 6, Issue 1, 2006, Pages 25-28

  Lueth, Stefan ^a   Lohse, Ansgar W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoantibodies; Cirrhosis; Gammaglobulin; Immunosuppression; Transaminases

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CALCIUM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SMOOTH MUSCLE ANTIBODY; VITAMIN D;

AUTOIMMUNE HEPATITIS; BONE MARROW SUPPRESSION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; HISTOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION TEST; LIVER TOXICITY; PANCREATITIS; PREVALENCE; REVIEW;

EID: 33644546020     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.6-1-25     Document Type: Review

References (12)

1. Mackay IR, Weiden S, Ungar B. Treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azathioprine. Lancet 1964;42:899-902.
2. O'Brien EN, Goble AJ, Mackay IR. Plasma-transaminase activity as an index of the effectiveness of cortisone in chronic hepatitis. Lancet 1958;i:1245-9.
3. Krawitt EL. Autoimmune hepatitis. Review. N Engl J Med 1996;334:897-903.
4. Boberg KM, Aadland E, Jahnsen J, Raknerud N et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998;33:99-103.
5. Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic hepatitis: a study of 68 patients. J Clin Gastroenterol 2002;35:75-81.
6. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996;110:848-57.
7. King's College group.
8. Kanzler S, Löhr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol 2001;39:339-41,344-8.
9. Kanzler S, Gerken G, Löhr H, Galle PR et al. Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol 2001;34:354-5.
10. Neuberger J, Portmann B, Calne R, Williams R. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 1984;37:363-5.
11. Gohlke F, Lohse AW, Dienes HP, Löhr H et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996;24:699-705.
12. Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S et al. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999;29:1078-84.